Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

JB93182

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Indoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based…
A new molecular modeling approach has been used to derive a pharmacophore of the potent and selective cholecystokinin-2 (CCK(2… Expand
Is this relevant?
2005
2005
Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists.
The systematic optimization of the structure of a novel 2,4,5-trisubstituted imidazole-based cholecystokinin-2 (CCK(2)) receptor… Expand
Is this relevant?
2005
2005
Pharmacological analysis of CCK2 receptors up-regulated using engineered transcription factors
Designed zinc finger proteins (ZFPs) regulate expression of target genes when coupled to activator or repressor domains… Expand
Is this relevant?
2002
2002
Pharmacological characterization of cholecystokinin receptors mediating contraction of human gallbladder and ascending colon
Cholecystokinin (CCK) produces contractions of gallbladder and colon in a number of different species. Although the effects of… Expand
Is this relevant?
2002
2002
Pharmacological analysis of CCK(2) receptor ligands using COS-7 and SK-N-MC cells, expressing the human CCK(2) receptor.
A series of CCK(2) receptor ligands were analysed with respect to their interaction with binding sites in the membranes of COS-7… Expand
Is this relevant?
2000
2000
2,7-Dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine as a new template for the design of CCK(2) receptor antagonists.
A novel series of nonpeptide CCK(2) receptor antagonists has been prepared, in which 2,7-dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h… Expand
Is this relevant?
Review
1999
Review
1999
CCK2 receptor antagonists: pharmacological tools to study the gastrin–ECL cell-parietal cell axis
Gastrin-recognizing CCK2 receptors are expressed in parietal cells and in so-called ECL cells in the acid-producing part of the… Expand
Is this relevant?
1999
1999
Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex
The previously described complex behaviour of the CCKB/gastrin receptor antagonist, L‐365,260, in radioligand binding assays… Expand
Is this relevant?
1997
1997
Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity.
Gastrin stimulates rat stomach enterochromaffin-like (ECL) cells via activation of cholecystokinin-B/gastrin receptors. The… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE